IRIS
FATUZZO, Pasquale Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.055
EU - Europa 4.443
AS - Asia 4.309
SA - Sud America 813
AF - Africa 427
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.058
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.696
SG - Singapore 2.411
RU - Federazione Russa 1.184
CN - Cina 1.115
IE - Irlanda 801
IT - Italia 801
UA - Ucraina 788
BR - Brasile 657
VN - Vietnam 338
CA - Canada 315
FR - Francia 272
CI - Costa d'Avorio 210
DE - Germania 190
SE - Svezia 109
NG - Nigeria 104
IN - India 102
GB - Regno Unito 99
KR - Corea 83
AR - Argentina 75
BD - Bangladesh 46
ZA - Sudafrica 31
NL - Olanda 30
SN - Senegal 29
MX - Messico 28
UZ - Uzbekistan 28
IQ - Iraq 27
PL - Polonia 27
CH - Svizzera 25
AT - Austria 21
TR - Turchia 21
EC - Ecuador 19
CO - Colombia 17
FI - Finlandia 17
GR - Grecia 17
JP - Giappone 17
KE - Kenya 17
ID - Indonesia 16
ES - Italia 15
HK - Hong Kong 15
MA - Marocco 14
PK - Pakistan 13
VE - Venezuela 13
PY - Paraguay 11
SA - Arabia Saudita 10
CL - Cile 9
AL - Albania 8
LB - Libano 8
IR - Iran 7
MY - Malesia 7
NP - Nepal 6
PH - Filippine 6
PT - Portogallo 6
AU - Australia 5
BG - Bulgaria 5
DZ - Algeria 5
JO - Giordania 5
LT - Lituania 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
EG - Egitto 4
ET - Etiopia 4
EU - Europa 4
HU - Ungheria 4
KZ - Kazakistan 4
OM - Oman 4
TT - Trinidad e Tobago 4
AO - Angola 3
BB - Barbados 3
BO - Bolivia 3
KW - Kuwait 3
RS - Serbia 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
MK - Macedonia 2
PS - Palestinian Territory 2
SM - San Marino 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
Totale 20.053
Salva come PNG Salva come JPEG
Città #
Dallas 1.446
Singapore 1.354
Houston 1.266
Santa Clara 983
Jacksonville 862
Dublin 800
Chandler 706
San Jose 572
Moscow 433
Ashburn 349
Boardman 345
Chicago 294
Nanjing 266
Andover 233
Lawrence 232
Cambridge 230
Toronto 225
Abidjan 210
Lauterbourg 207
Beijing 139
Des Moines 132
Los Angeles 130
Ho Chi Minh City 125
Catania 120
San Mateo 117
Wilmington 102
Grafing 93
Seoul 83
Nanchang 81
Shenyang 80
Saint Petersburg 75
Council Bluffs 73
New York 73
Hanoi 69
Buffalo 59
Civitanova Marche 58
Hebei 57
Hefei 53
São Paulo 52
Abuja 51
Ottawa 51
Jiaxing 50
Lagos 48
Rome 45
Changsha 44
Tianjin 38
Milan 37
Bremen 32
Orem 30
Dakar 29
Kochi 29
Rio de Janeiro 29
Seattle 25
Brooklyn 21
Montreal 20
Pune 20
The Dalles 20
Columbus 18
Dong Ket 18
Chennai 17
Tokyo 17
Amsterdam 16
Atlanta 16
Da Nang 16
Johannesburg 16
Denver 15
Norwalk 15
Nuremberg 15
Boston 14
Hangzhou 14
Redondo Beach 14
Stockholm 14
Warsaw 14
Haiphong 13
Helsinki 13
London 13
Florence 12
Guarulhos 12
Mumbai 12
Padova 12
Poplar 12
San Francisco 12
Charlotte 11
Curitiba 11
Guayaquil 11
Kunming 11
Ningbo 11
Noto 11
Zhengzhou 11
Baghdad 10
Belo Horizonte 10
Buenos Aires 10
Dhaka 10
Guangzhou 10
Hong Kong 10
Liberty Lake 10
Nairobi 10
Palermo 10
Porto Alegre 10
Biên Hòa 9
Totale 13.949
Salva come PNG Salva come JPEG
Nome #
Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients 937
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis 330
Molecular and clinical studies in five index cases with novel mutations in the GLA gene 302
Microplastics exposure in dialysis patients: preliminary results of a case-control study 212
LA DIMETILARGININA ASIMMETRICA (ADMA) INTERAGISCE CON L’FGF-23 NEL PREDIRE LA PROGRESSIONE DEL DANNO RENALE NEI PAZIENTI CON STADIO 2-5 DI MALATTIA RENALE CRONICA 206
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 189
A systematic review of arterial stiffness, wave reflection and air pollution 188
ADPKD: valutazione di patologia cistica epididimaria e quadro spermatico 167
Aferesi terapeutica in paziente con crioglobulinemia (contributo clinico) 166
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease 153
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 153
Arteriovenous fistula and pre-surgery mapping: Potential role of physical exercise on endothelial function 153
Alterazioni carotidee nell’insufficienza renale cronica 145
Asymmetric dimethylarginine (ADMA),left ventricular hypertrophy and systolic dysfunction in hemodialysis patients 144
Aberrant right subclavian artery laceration due to internal jugular vein catheterization treated by stent -graft implantation 143
Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: A prospective cohort study in outpatient renal clinics 138
ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVELS IN CHRONIC KIDNEY DISEASE: A SALTY QUESTION? 137
Il Fosforo: nuovo fattore di rischio cardiovascolare? [Phosphorus: A new cardiovascular risk factor?] 137
Alterazioni carotidee in corso di insufficienza renale cronica 132
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention 132
Pazienti con insufficienza renale cronica: risultati dallo studio Nefrodata [Characteristics of patients with chronic kidney disease referred to a nephrology outpatient clinic: results of Nefrodata study] 130
Eventi avversi e trigger C12: Stroke in ospedale 130
Atrial Natriuretic Peptide (ANP), Brain Natriuretic Peptide (BNP) and Left Atrial Volume: a longitudinal study in End Stage Renal Disease (ESRD) patients. JASN 2008;19:719A. 128
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 128
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients 126
Wegener: nostro contributo clinico 121
PLASMA CONCENTRATION OF ASYMMETRICAL DYMETHYLARGININE AND MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE: “A PROSPECTIVE STUDY” . 119
Arterial pressure determinant of LVH in uremic patients. 119
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 118
ADPKD:rilevanza del rischio cardio-vascolare in un gruppo di pazienti non complianti alla terapia antipertensiva. 117
Aspergillosis in Hemodialysis Patient 114
An Unusual Association: Fahr's Syndrome And Chronic Kidney Disease 114
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients. 113
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study 110
Sepsi e Polimixina (contributo) 110
La PET con C-Metionina: un approccio propositivo nel trattamento dell'iperparatiroidismo 110
raised Asymmetric Dimethyl Arginine is Associated With High Plasma Norepinephrine in Patients with ESRD 109
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 106
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease 105
Ascessi Renali:patologia emergente in soggetti di giovane età 105
Rapporti dei peptidi natriuretici con la struttura e la funzione cardiaca nell'insufficienza renale cronica terminale: analogie e differenze tra ANP, BNP, CNP e DNP. 104
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease 103
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism 102
LIVELLI DI PTX 3 IN PAZIENTI CON INSUFFICIENZA RENALE CRONICA (IRC) 102
Valutazione clinica dell'efficacia terapeutica dell'acebutololo nell'ipertensione arteriosa. 102
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients 101
Vascular dysfunction in Cardiorenal Syndrome type 4 100
IL2 and its receptors in elderly subjects on hemodialysis 99
LIVELLI PLASMATICI DELLE PENTRAXINE “SHORT” (PROTEINA C REATTIVA) E DELLE PENTRAXINE “LONG” (PTX3) NELLA INSUFFICIENZA RENALE E NEL TRATTAMENTO EMODIALITICO 99
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 98
Letter regarding the article "The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study". 96
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 96
Metformin and kidney 96
DIAGNOSTIC POTENZIAL OF CARDIAC NATRIURETIC PEPTIDES IN DIALYSIS PATIENTS 95
Complicanze tardive legate al posizionamento del catetere venoso centrale: le complicanze meccaniche 95
Utilità dell’sCD14-ST per la diagnosi di sepsi nel paziente con insufficienza renale [Usefulness of sCD14-ST in the diagnosis of sepsis in patient with renal failure] 94
Magnesium, calcium and potassium: "no one was born alone" 94
Ultrasuoni versus rx nella dislocazione del catetere peritoneale: mito o raltà? 94
Il paradosso nefrologico 94
Digoxin and Hypermagnesuria 94
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? 93
Peritonite da Candida e sepsi da Acinetobacter baumannii in dialisi peritoneale: una associazione con la prognosi non è sempre sfavorevole 93
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure 93
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 92
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery disease 92
L’IMMUNITÀ INNATA E LA PROGRESSIONE DELLA MALATTIA RENALE CRONICA 91
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients 90
Review: UPDATE sul metabolismo del magnesio 90
L’interleuchina-6 è implicata in maniera causale nell’alto rischio cardiovascolare della malattia renale cronica: uno studio di randomizzazione mendeliana 90
Gli inibitori del trasportatore Sodio-Glucosio di tipo 2 (SGLT2) nell’insufficienza renale cronica [Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors in CKD] 90
CHLAMYDIA PNEUMONIAE, OVERALL AND CARDIOVASCULAR MORTALITY IN END STAGE RENAL DISEASE 88
Ruolo della Dialisi Peritoneale nel trattamento dei Pazienti con Scompenso Cardiaco Congestizio 88
Comparative study of biochemical markers of bone formation in relation to different dialysis age 87
Heart rate, age and the risk progression to kidney failure in patients with CKD 87
Prevalenza degli anticorpi sierici anti-virus dell'epatite C in pazienti emodializzati. 87
Il fumo, la pressione arteriosa e l'albuminemia sono fattori predittivi indipendenti dal danno vascolare negli uremici in dialisi 87
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the excite trial 87
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 87
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients 87
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 87
ITALIAN AUDIT ON THERAPY OF HYPERTENSION IN CHRONIC KIDNEY DISEASE: TABLE-CKD STUDY 86
Il rituximab nella terapia delle glomerulonefriti primitive e secondarie [Use of rituximab in primary and secondary glomerulonephritis] 86
Psichiatria di Liaison:Contributo sperimentale allo studio della Qualità di dei DializzatiVita 85
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 85
Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease 84
Diagnosis of renovascular disease by extra-end intrarenal doppler parameters 83
Valutazione del Filtrato Glomerulare prima edopo Regime proteico Controllato 83
Comportamento delle transaminasi sieriche in corso di infezione da HBV e HCV in pazienti emodializzati 82
Renal transplantation parenchymal complications: what Doppler ultrasound can and cannot do 82
Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients 82
Color Doppler ultrasound and arteriovenous fistulas for hemodialysis 82
Manuale italiano di cateterismo venoso centrale in nefrologia : Dalla teoria alla pratica clinica quotidiana 82
The effect of tumor necrosis factor antagonists on functional aortic stiffening 82
Propyonil-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease (PAD) and end stage renal disease (ESRD) 82
Circulating E-selectin as a risk marker in patients with end-stage renal disease 81
STUDIO SIR-SIN ( STUDIO ITALIANO INDICATORI DI RISULTATO MULTIPLI-EPIDEMIOLOGIA DELL’IRC IN ITALIA DELLA SOCIETA’ ITALIANA DI NEFROLOGIA) NELLA POPOLAZIONE AFFETTA DA IRC IN TERAPIA CONSERVATIVA. DATI PRELIMINARI 81
Pyelonephritis: Epidemiology, pathogenesis and management 81
THE ENDOGENOUS INHIBITOR OFF e NOs ASIMMETRIC DIMETHYLARGININE (ADMA) IS HIGHER IN CAPD THAN IN HD PATIENTS 81
High Variability of Fabry Disease Manifestations in an Extended Italian Family 81
Inflammation and aortic stiffness: An individual participant data meta-analysis in patients with inflammatory bowel disease 81
Totale 11.992
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.239
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 0 0 0 0 0 0 0 0 0 12 174 53
2021/20221.671 224 250 4 22 262 12 245 63 166 1 41 381
2022/20232.278 249 69 35 180 215 454 5 376 590 15 73 17
2023/2024942 62 202 61 60 34 104 18 51 4 37 205 104
2024/20253.756 34 623 240 159 815 397 44 153 330 416 227 318
2025/20267.209 415 205 1.531 495 1.284 1.280 1.105 168 373 353 0 0
Totale 20.445